Evidence map›Paper›PMID 41836822›Full record

ArticlePakistan journal of medical sciences2026

Clinical diagnostic value of the plasma heparin binding protein in diabetic nephropathy patients comorbid with sepsis.

Lulu Han, Shenghai Wang, Zhao Wang

Abstract read
In one paragraph

Article in Pakistan journal of medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lulu HanLulu Han Department of Endocrinology, Baoding No.1 Central Hospital, Baoding 071000, Hebei, China.
Shenghai WangShenghai Wang Intensive Care Unit, Affiliated Hospital of Hebei University, Baoding 071000, Hebei, China.
Zhao WangZhao Wang Department of Endocrinology, Baoding No.1 Central Hospital, Baoding 071000, Hebei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To explore the clinical diagnostic value of plasma heparin binding protein in diabetes nephropathy (DN) with sepsis. Methodology: The study was a retrospective study of 82 patients with DN, carried out in Affiliated Hospital of Hebei University from April 2024 to December 2024. Information about inflammatory indicators, biochemical, glucose metabolism and urine microalbumin indicators. Patients were divided into two major groups, DN sepsis group (n=42) and DN group (n=40). Date of 40 T2DM patients were used as the normal control group. The inter group comparison was conducted using analysis of variance, Pearson correlation analysis was used to analyze the correlation between HBP and BUN, Scr, UACR, and eGFR, and receiver operating characteristic (ROC) curve analysis was used to evaluate the specificity and sensitivity of inflammatory indicators, and to evaluate their diagnostic efficiency for DN patients with sepsis. Results: Compared with DN and T2DM groups, HBP, CRP and PCT were dramatically increased in DN sepsis group (p<0.001), ESR and NE% also higher (p<0.05). In DN group, HBP exhibited an upward trend (p<0.05) than T2DM group. The serum HBP was positively correlated with BUN, Scr and UACR, negatively correlated with eGFR in DN patients. In the early stage of sepsis in DN patients, the area under the curve (AUC) of HBP is 0.691. Conclusion: The plasma HBP were dramatically increased in DN patients comorbid with sepsis, plasma HBP clinical testing were essential and had high-efficiency clinical diagnosis abilities of sepsis in DN patients.

Indexed as

Diabetic nephropathyDiagnostic valueHeparin binding proteinSepsis

Identifiers

PMID41836822
PMCPMC12980286

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.